Nanostics is pleased to announce the launch of clinical validation study
EDMONTON, June 4, 2019 /CNW/ – Nanostics Inc. is pleased […]
EDMONTON, June 4, 2019 /CNW/ – Nanostics Inc. is pleased […]
APCaRI, represented by John Lewis and Catalina Vasquez, met with […]
The PRIME Study – Prevention and Intervention for MEtabolic syndrome: […]
“We have enrolled over 400 patients at our site, reaching […]
APCaRI is committed to collecting, processing and storing the samples […]
A new test to better diagnose prostate cancer has been developed by APCaRI members and it’s getting attention from the media. Last week, Global News Calgary interviewed Dr. John Lewis to hear more about the new test. Here is the link with the whole interview.